Magnetic Resonance Spectroscopy: Clinical Trials

2,074 trials of Magnetic Resonance Spectroscopy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

672 completed, 538 recruiting, 323 active not recruiting, 156 terminated. 673 Phase 2, 485 Not applicable, 380 Phase 1, 182 Phase 3, 79 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2673Recruiting 240, Active not recruiting 168, Completed 114, Terminated 43, Withdrawn 39, Not yet recruiting 34, Suspended 23, Unknown 9, Enrolling by invitation 3
Not applicable485Completed 234, Recruiting 71, Unknown 58, Terminated 40, Withdrawn 36, Active not recruiting 31, Not yet recruiting 12, Enrolling by invitation 3
Phase 1380Recruiting 134, Active not recruiting 76, Completed 70, Terminated 35, Withdrawn 22, Not yet recruiting 20, Suspended 20, Unknown 3
Phase 3182Recruiting 65, Active not recruiting 54, Completed 32, Not yet recruiting 11, Suspended 7, Terminated 7, Unknown 4, Withdrawn 2
Early Phase 179Completed 36, Recruiting 18, Terminated 9, Active not recruiting 8, Withdrawn 6, Unknown 2
Phase 435Completed 16, Recruiting 8, Terminated 5, Unknown 4, Enrolling by invitation 1, Not yet recruiting 1

Follow Magnetic Resonance Spectroscopy: new trials by email Literature Review of Magnetic Resonance Spectroscopy trials Research Report on Magnetic Resonance Spectroscopy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma
Phase 2Not yet recruitingNorthwestern University442027-12-102026-06-10
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Phase 1Not yet recruitingNorthwestern University182027-09-092026-10-20
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2Not yet recruitingCity of Hope Medical Center442027-08-042026-09-10
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset
Phase 1Not yet recruitingColumbia University62027-08-012026-05-13
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)762027-06-252026-10-22
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
Biospecimen Collection, Carboplatin, Computed Tomography - Lung Non-Squamous Non-Small Cell Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center162027-06-012026-02-05
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma
Phase 2Not yet recruitingNorthwestern University562027-05-052026-10-07
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)742027-04-202026-10-07
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
Biospecimen Collection, Computed Tomography, Positron Emission Tomography - Recurrent Plasmablastic Lymphoma, Refractory Plasmablastic Lymphoma
Phase 1RecruitingNational Cancer Institute (NCI)302027-03-262026-10-20
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3RecruitingSWOG Cancer Research Network5622027-03-092026-10-13
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma
Phase 1Not yet recruitingCity of Hope Medical Center242027-02-172026-08-27
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)392027-02-132026-09-03
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
Biospecimen Collection, Computed Tomography, Electronic Health Record Review - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
Phase 2Not yet recruitingNorthwestern University1252027-02-032026-08-06
Comparing Radiation After Surgery to Observation After Surgery in Patients With Clinical Low-Risk, Molecular High-Risk Meningioma, and Evaluating Observation After Surgery in Patients With Clinical and Molecular Low-Risk Meningioma
Patient Observation, Magnetic Resonance Imaging, Biospecimen Collection - Grade 1 Meningioma, Grade 2 Meningioma
Phase 3Not yet recruitingNRG Oncology4642027-01-282026-08-25
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy - Acute Myeloid Leukemia
Phase 2Not yet recruitingNational Cancer Institute (NCI)2442027-01-152026-10-20

Showing 20 of 2074. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (168)  ·  Breast Neoplasms (123)  ·  Lung Neoplasms (105)  ·  Carcinoma, Non-Small-Cell Lung (85)  ·  Glioblastoma (81)  ·  Brain Neoplasms (76)  ·  Glioma (70)  ·  Neoplasm Metastasis (68)  ·  Pancreatic Neoplasms (53)  ·  Neoplasms (48)  ·  Carcinoma, Renal Cell (47)  ·  Colorectal Neoplasms (47)  ·  Multiple Myeloma (46)  ·  Lymphoma, Large B-Cell, Diffuse (42)  ·  Squamous Cell Carcinoma of Head and Neck (40)

Sponsors

National Cancer Institute (NCI) (326)  ·  Mayo Clinic (125)  ·  City of Hope Medical Center (86)  ·  M.D. Anderson Cancer Center (76)  ·  Jonsson Comprehensive Cancer Center (58)  ·  University of Washington (46)  ·  Emory University (34)  ·  NRG Oncology (30)  ·  Children's Oncology Group (29)  ·  Alliance for Clinical Trials in Oncology (28)  ·  Memorial Sloan Kettering Cancer Center (28)  ·  University of California, San Francisco (26)  ·  Roswell Park Cancer Institute (25)  ·  OHSU Knight Cancer Institute (23)  ·  Ohio State University Comprehensive Cancer Center (23)

Countries

United States (1499)  ·  Canada (170)  ·  France (133)  ·  United Kingdom (80)  ·  Puerto Rico (62)  ·  Australia (40)  ·  Switzerland (34)  ·  China (27)  ·  Germany (26)  ·  Netherlands (23)  ·  Belgium (21)  ·  Denmark (21)  ·  South Korea (17)  ·  New Zealand (15)  ·  Sweden (15)

Top investigators

Andrei Iagaru (9)  ·  Jeremie Calais (8)  ·  Thomas Hope, MD (7)  ·  Hannah Linden (6)  ·  Ibrahim Aldoss (5)  ·  Jeremie Calais, MD (5)  ·  Rahul Aggarwal, MD (5)  ·  Sabine Mueller, MD, PhD (5)  ·  Terence C. Burns, MD, PhD (5)  ·  Andrea B Apolo (4)  ·  Behnam Badie (4)  ·  Charles Marmar, MD (4)  ·  Haider S Mahdi (4)  ·  Ivan de Kouchkovsky, MD (4)  ·  Jason M Johnson (4)

Results publications

PMID 41698328, PMID 37505794, PMID 21796368, PMID 22198468, PMID 22649152, PMID 25009491, PMID 25120466, PMID 25680307, PMID 25964753, PMID 26157378, PMID 26659347, PMID 27695404, PMID 30573690, PMID 30832656, PMID 31375469, PMID 31401903, PMID 33395032, PMID 33452634, PMID 33602654, PMID 33674398, PMID 34081125, PMID 34241652, PMID 34406051, PMID 35031545, PMID 35175355, PMID 35861811, PMID 36512649, PMID 37185961, PMID 37222189, PMID 37555901, PMID 38421243, PMID 39146945, PMID 39571596, PMID 39836610, PMID 40135712, PMID 41747891, PMID 41911908, PMID 10633896, PMID 10813118, PMID 11078769, PMID 11182734, PMID 11936199, PMID 12411660, PMID 12548202, PMID 12642576, PMID 14688710, PMID 15163933, PMID 15599396, PMID 15800894, PMID 15960763

NIH funding

P30CA033572 (77), U10CA180820 (65), U10CA180868 (55), U10CA180888 (46), U10CA180886 (44), U10CA180821 (42), P30CA138292 (28), P30CA060553 (27), UM1CA186689 (21), UM1CA186691 (18), UM1CA186709 (15), UM1CA186690 (14), UM1CA186712 (14), UM1CA186717 (12), P30CA014089 (11)